H3K27三甲基化缺失在脑膜瘤中的新兴意义:复发与总生存的系统综述与Meta分析
该研究系统检索7个数据库至2021年10月,纳入7项回顾性队列研究共2180例脑膜瘤患者,评估H3K27me3缺失的预后价值。Meta分析显示H3K27me3缺失合并发生率为15%(95%CI 8%-24%),复发多因素HR为1.77(95%CI 1.23-2.31;P<0.01),提示H3K27me3缺失与脑膜瘤复发独立相关,但作者指出需更稳健数据支持。
要点
- H3K27me3缺失在脑膜瘤中的合并发生率为15%(95%CI 8%-24%)。
- H3K27me3缺失与复发风险独立相关,多因素HR为1.77(95%CI 1.23-2.31;P<0.01)。
- 4项研究中有2项单因素分析显示H3K27me3缺失者总生存更短,2项多因素分析描述显著关联。
核心结论
- 当代Meta分析数据支持H3K27me3缺失与脑膜瘤复发率更高独立相关,差异有统计学意义。
- 作者认为该效应在2级脑膜瘤中可能更明显,但需要更稳健的数据和分析来支持这一观点。
研究设计与样本
- 遵循PRISMA指南,检索7个电子数据库自建库至2021年10月,按预设标准筛选文献。
- 最终纳入7项回顾性队列研究,共2180例脑膜瘤患者(男性1291例[59%];平均年龄56岁)。
- 采用随机效应Meta分析合并比例数据(可行时)。
主要发现
- 7项研究中H3K27me3缺失的合并发生率为15%(95%CI 8%-24%)。
- 6项研究中复发的多因素校正HR合并估计为1.77(95%CI 1.23-2.31;P<0.01)。
- 4项研究中2项(50%)单因素分析显示H3K27me3缺失者总生存显著更短,2项研究多因素分析描述H3K27me3缺失与总生存更短显著相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者指出需要更稳健的数据和分析来支持H3K27me3缺失效应在2级脑膜瘤中更明显的观点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: It has been proposed in the most recent 2021 World Health Organization classification of brain tumors that the loss of trimethylation at histone 3 lysine site 27 (H3K27me3) might prognosticate meningioma outcomes. However, to date, the emerging literature has remained diffuse in its stance. Thus, the aim of the present study was to determine the prognostic relevance of H3K27me3 loss in meningioma. METHODS: Searches of 7 electronic databases from inception to October 2021 were conducted in accordance with the PRISMA (preferred reporting items for systematic reviews and meta-analyses) guidelines. Articles were screened against prespecified criteria. Outcomes were pooled by random effects meta-analyses of proportions, where possible. RESULTS: A total of 7 retrospective cohort studies satisfied all the criteria, with a total of 2180 meningioma patients overall (1291 male patients [59%]; mean age, 56 years). Across all 7 studies, the pooled incidence of H3K27me3 loss was estimated at 15% (95% confidence interval, 8%-24%). Across 6 studies, the pooled multivariate-derived hazard ratio estimate for recurrence was 1.77 (95% confidence interval, 1.23-2.31; P < 0.01). Overall survival on univariate analysis was significantly shorter with H3K27me3 loss in 2 of 4 studies (50%), and 2 studies had described a significant association between H3K27me3 loss and shorter overall survival on multivariate analysis. CONCLUSIONS: The contemporary metadata favor a greater incidence of meningioma recurrence based independently on H3K27me3 loss, with a statistically significant difference. It is possible that these effects are more pronounced for grade 2 meningiomas; however, more robust data and analysis are needed to augment this position.
引用
- Lu VM, Luther EM, Eichberg DG, et al. The Emerging Relevance of H3K27 Trimethylation Loss in Meningioma: A Systematic Review of Recurrence and Overall Survival with Meta-Analysis. World Neurosurg. 2022. PMID: 35439620. doi:10.1016/j.wneu.2022.04.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。